Development of resveratrol loaded chitosan-gellan nanofiber as a novel gastrointestinal delivery system.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
15 Aug 2019
Historique:
received: 08 03 2019
revised: 17 05 2019
accepted: 26 05 2019
pubmed: 31 5 2019
medline: 18 12 2019
entrez: 31 5 2019
Statut: ppublish

Résumé

Resveratrol loaded chitosan:gellan (CS:Gel) nanofibers (NFs) were prepared for the first time using electrospinning technique. The NFs were prepared with CS (9% w/v) in trifloroacetic acid and Gel (2.5% w/v) at a concentration ratio of 95:5% w/v. Based on the scanning electron microscopy (SEM) images, the diameters of CS-Gel fibers at a ratio of 95:5 and 90:10% w/v were 166 ± 37 and 291 ± 41 nm, respectively. Resveratrol (0.05% w/v) was loaded in NFs of CS-Gel at a ratio of 95:5. Encapsulation efficiency (EE) of resveratrol in NFs of CS-Gel were 86 ± 6%. The amount of resveratrol delivered in intestine region was in the range of 43-51% of the total encapsulated resveratrol (equivalent to ~840 μM). Antioxidant activities of resveratrol loaded NFs were significantly higher than that of free resveratrol. Furthermore, the resveratrol releasing ability of the NFs was proved through the MTT assay and revealed that the resveratrol NFs have almost the same cytotoxicity against HT29 cancer cells compared to free resveratrol. Based on the obtained results, the prepared NFs hold great potential as drug delivery carriers for resveratrol delivery.

Identifiants

pubmed: 31145955
pii: S0141-8130(19)31764-7
doi: 10.1016/j.ijbiomac.2019.05.187
pii:
doi:

Substances chimiques

Drug Carriers 0
Polysaccharides, Bacterial 0
gellan gum 7593U09I4D
Chitosan 9012-76-4
Resveratrol Q369O8926L

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

698-705

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Mohammadreza Rostami (M)

Department of Food Science and Technology, Faculty of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, Iran.

Marjan Ghorbani (M)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Masoud Aman Mohammadi (M)

Student Research Committee, Department of Food Technology, Faculty of Nutrition Sciences and Food Technology/National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mostafa Delavar (M)

Department of Pharmacology, Arak University of Medical Science, Arak, Iran.

Mahnaz Tabibiazar (M)

Nutrition Research Center and Department of Food Science and Technology, Faculty of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: tabibiazarm@tbzmed.ac.ir.

Soghra Ramezani (S)

Trita Nanomedicine Research Center, Trita Pharmaceuticals, Zanjan, Iran. Electronic address: ramazanisog@aut.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH